Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Enteric-coated Anise-oil Capsules in Irritable Bowel Syndrome
NCT02364830Phase 3Completed
- Sponsor
- Shiraz University of Medical Sciences
- Start
- Apr 2013
- Primary completion
- Jan 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of Anise oil in irritable bowel syndrome (IBS) (3 arms), sponsored by Shiraz University of Medical Sciences. Primary endpoint: Composite of Quality of Life (QOL), pain, flatulence, diarrhea, constipation, reflux, headache and tiredness. Started Apr 2013; status: completed.
02
Drugs
Anise oil
03
Conditions
irritable bowel syndrome (IBS)
Beyond the preview
Go deeper on NCT02364830.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02364830.